Effect of Alpha-1-Adrenergic Agonist, Midodrine for the Management of Long-Standing Neurogenic Shock in Patient with Cervical Spinal Cord Injury: A Case Report

We report a rare case of a 71-year-old male patient who had suffered from long-lasting neurogenic shock for 13 weeks after cervical spinal cord injury (SCI) caused by a bicycle accident. The neurogenic shock was resolved dramatically 2 weeks after the administration of alpha-1-adrenergic agonist, midodrine hydrochloride. In usual cases, neurogenic shock tends to improve between 2 and 6 weeks after SCI; however, in a few cases, the shock lasts for several months. In our case, spinal shock lasted for 13 weeks and exhibited very sensitive decline of blood pressure for even a slight decrease of dopamine despite recovered bulbospongiosus reflex. Three days after midodrine hydrochloride was added, hypotension improved dramatically. We discuss our rare case with pertinent literatures.

[1]  Sean Christie,et al.  A systematic review of intensive cardiopulmonary management after spinal cord injury. , 2011, Journal of neurotrauma.

[2]  T. Rekand,et al.  Cardiovascular and urological dysfunction in spinal cord injury , 2011, Acta neurologica Scandinavica. Supplementum.

[3]  R. Freeman,et al.  Neurogenic orthostatic hypotension. , 2008 .

[4]  R. Freeman,et al.  Clinical practice. Neurogenic orthostatic hypotension. , 2008, The New England journal of medicine.

[5]  S. Hinderer,et al.  Double-Blinded, Placebo-Controlled Trial Of Midodrine For Exercise Performance Enhancement In Tetraplegia:A Pilot Study , 2004, The journal of spinal cord medicine.

[6]  O. Thulesius,et al.  Vasoconstrictor effect of midodrine, ST 1059, noradrenaline, etilefrine and dihydroergotamine on isolated human veins , 2004, European Journal of Clinical Pharmacology.

[7]  Jon A. Mukand,et al.  Midodrine for the management of orthostatic hypotension in patients with spinal cord injury: A case report. , 2001, Archives of physical medicine and rehabilitation.

[8]  A. Krassioukov,et al.  Cardiovascular consequences of loss of supraspinal control of the sympathetic nervous system after spinal cord injury. , 2000, Archives of physical medicine and rehabilitation.

[9]  SJ Rogers,et al.  Midodrine hydrochloride and the treatment of orthostatic hypotension in tetraplegia: two cases and a review of the literature , 2000, Spinal Cord.

[10]  P. Low,et al.  A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension , 1998, Neurology.

[11]  K. Goa,et al.  Midodrine. A review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders. , 1989, Drugs.